Hemab Therapeutics Holdings, Inc. Common Stock (COAG) is a publicly traded the market company. As of July 13, 2026, COAG trades at $39.51 with a market cap of $1.78B and a P/E ratio of 0.00. COAG moved +4.50% today. Year to date, COAG is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $23.00 to $42.03. Analyst consensus is strong buy with an average price target of $41.40. Rallies surfaces COAG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for COAG shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $39.51 |
| Market Cap | $1.78B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $42.03 |
| 52-Week Low | $23.00 |
| Volume | 348.86K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
5 analysts cover COAG: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $41.40.